| Literature DB >> 25473056 |
Michael Lauck1, Adam L Bailey1, Kristian G Andersen2, Tony L Goldberg3, Pardis C Sabeti2, David H O'Connor4.
Abstract
In 49 patients with known Ebola virus disease outcomes during the ongoing outbreak in Sierra Leone, 13 were coinfected with the immunomodulatory pegivirus GB virus C (GBV-C). Fifty-three percent of these GBV-C(+) patients survived; in contrast, only 22% of GBV-C(-) patients survived. Both survival and GBV-C status were associated with age, with older patients having lower survival rates and intermediate-age patients (21 to 45 years) having the highest rate of GBV-C infection. Understanding the separate and combined effects of GBV-C and age on Ebola virus survival may lead to new treatment and prevention strategies, perhaps through age-related pathways of immune activation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25473056 PMCID: PMC4338908 DOI: 10.1128/JVI.02752-14
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103